Legend Biotech (LEGN) Change in Cash (2019 - 2025)

Legend Biotech has reported Change in Cash for 7 years, with the latest figure at $623.0 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Cash rose 460.95% year-over-year to $623.0 million; the trailing twelve-month figure through Dec 2025 stood at $615.1 million (up 162.07% YoY), and the FY2025 full-year result was $615.2 million, up 162.08% from the prior year.
• Change in Cash for Q4 2025 stood at $623.0 million, up from $18.1 million in the prior quarter.
• The five-year high for Change in Cash was $623.0 million in Q4 2025, with the low at -$696.3 million in Q2 2024.
• Historically, Change in Cash has averaged $22.4 million across 5 years, with a median of -$11.4 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Cash slumped 611.55% — and 2023, when it surged 19899.89%.
• Legend Biotech's Change in Cash stood at $350.5 million in 2021, then tumbled by 107.3% to -$25.6 million in 2022, then jumped by 1322.17% to $312.8 million in 2023, then slumped by 155.18% to -$172.6 million in 2024, then soared by 460.95% to $623.0 million in 2025.
• The last three Change in Cash figures came in at $623.0 million (Q4 2025), $18.1 million (Q3 2025), and -$179.6 million (Q2 2025), per Business Quant data.